Akhila.jpg

Ms. Akhila Kamidi

M.Sc. (Biotechnology)

TCABS-E Scientist,

Program Manager,

RNA Biology, 

Department of Intramural Research Core (IRC)

The Center for Advanced-Applied Biological Sciences & Entrepreneurship (TCABS-E), Visakhapatnam (A.P.) India.

Telephone: +91 8660301662; Email: tcabse.india(at)gmail(dot)com.

Research Interests: LINC-RNA Therapeutics: Long intergenic non-coding RNA (LINC-RNA) molecules are critical in gene regulation via their sponging mechanism in controlling the micro-RNA molecules. LINC-RNA molecules are usually big and are structurally unstable due to which they have not been used effectively as therapeutics. My goal is to employ the LINC-RNA molecules as therapeutics mainly in Oncology for the suppression of genes, by stabilizing them using chemical biology approach.

LINC-RNA.png

Publications (Listed Chronologically)

  1. Kamidi, A. and Yedidi, R.S. (2021). Chemical biology-based strategies to stabilize the secondary structure of dynamic ceRNA molecules for detection and activation of p53 gene in colorectal cancer. TCABSE-J, Vol. 1, Issue 2:35-37. Epub: Oct 15th , 2021. (View publication)​

  2. Addala, S., Vissapragada, M., Aggunna, M., Mukala, N., Lanka, M., Gampa, S., Sodasani, M., Chintalapati, J., Kamidi, A., Veeranna, R.P., Yedidi, R.S. (2022) Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design. Vaccines. 2022; 10(6):841. https://doi.org/10.3390/vaccines10060841